Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0MGBOF
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
huNb26/Nb26-Nbh-MMAE
|
|||||
| Synonyms |
huNb26/Nb26-Nbh-MMAE
Click to Show/Hide
|
|||||
| Organization |
Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1
|
|||||
| Structure |
|
|||||
| Antibody Name |
huNb26/Nb26-Nbh
|
Antibody Info | ||||
| Antigen Name |
Nectin-4 (NECTIN4)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Mc-Val-Cit-PABC
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
Vedotin
|
|||||
General Information of The Activity Data Related to This ADC
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | 44.63 nM | Low NECTIN4 expression (NECTIN4+) | ||
| Method Description |
Cells in the exponential growth phase were harvested and seeded at a density of 4 × 103 cells per well into 96-well plates, followed by overnight incubation. The 96-well plate was filled with gradient dilutions of the NDC along with complete growth medium. Cells were incubated at 37 °C for 96 h. 20 uL of cell counting Kit-8 (Dojindo) was administered to the cells, which were then incubated at 37 °C for 4 h. After shaking the 96-well plates, absorbance was measured at 450 nm using an enzyme marker. Inhibition % = (1 - absorbance of experimental group) / average absorbance of blank group × 100. IC50 values were ascertained by non-linear regression analysis utilizing GraphPad Prism version 8.0.
Click to Show/Hide
|
||||
| In Vitro Model | Gastric tubular adenocarcinoma | NCI-N87 cells | CVCL_1603 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Effective Concentration (EC50) | 1.04 nM | Low NECTIN4 expression (NECTIN4+) | ||
| Method Description |
Cells in the exponential growth phase were harvested and seeded at a density of 4 × 103 cells per well into 96-well plates, followed by overnight incubation. The 96-well plate was filled with gradient dilutions of the NDC along with complete growth medium. Cells were incubated at 37 °C for 96 h. 20 uL of cell counting Kit-8 (Dojindo) was administered to the cells, which were then incubated at 37 °C for 4 h. After shaking the 96-well plates, absorbance was measured at 450 nm using an enzyme marker. Inhibition % = (1 - absorbance of experimental group) / average absorbance of blank group × 100. IC50 values were ascertained by non-linear regression analysis utilizing GraphPad Prism version 8.0.
Click to Show/Hide
|
||||
| In Vitro Model | Gastric tubular adenocarcinoma | NCI-N87 cells | CVCL_1603 | ||
References
